Recruiting Lymphoma Studies in Wilmington
Confirmatory Study of Topical HyBryteâ„¢ vs. Placebo for the Treatment of CTCL
To evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides)....
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
The purpose of this study is to assess the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refracto...
About Lymphoma Clinical Trials in Wilmington
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Wilmington, DE. These studies are seeking a combined 148 participants. Research is being sponsored by Soligenix, Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Wilmington — FAQ
Are there lymphoma clinical trials in Wilmington?
Yes, there are 2 lymphoma clinical trials currently recruiting in Wilmington, DE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Wilmington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.
Are clinical trials in Wilmington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov